The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain pill aimed at reducing addiction and overdose risks associated with opioids. While it shows promise in providing relief, its effectiveness is modest compared to traditional opioids. The drug works by blocking pain signals before they reach the brain, differing from the mechanism of opioids. Common side effects include nausea and headache, and it is not yet approved in the EU. Teljes cikk (Euronews.com)